Nkarta, Inc. (NKTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Paul J. Hastings
Employees:
130
6000 SHORELINE COURT, SUITE 102, SOUTH SAN FRANCISCO, CA 94080
650-215-0385

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens.

Data derived from most recent annual or quarterly report
Market Cap 187.445 Million Shares Outstanding48.814 Million Avg 30-day Volume 468.138 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.58
Price to Revenue0.0 Debt to Equity0.0 EBITDA-90.15 Million
Price to Book Value3.2161 Operating Margin0.0 Enterprise Value718.168 Million
Current Ratio36.104 EPS Growth0.622 Quick Ratio35.66
1 Yr BETA 1.5863 52-week High/Low 20.35 / 3.57 Profit Margin0.0
Operating Cash Flow Growth-136.8705 Altman Z-Score37.4431 Free Cash Flow to Firm -45.021 Million
View SEC Filings from NKTX instead.

View recent insider trading info

Nkarta, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NKTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NKTX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-18 by TRAGER JAMES
  • 4: filed on 2023-01-18 by SHOOK DAVID
  • 4: filed on 2023-01-18 by MAHMOOD NADIR
  • 4: filed on 2023-01-18 by HASTINGS PAUL J
  • 4: filed on 2023-01-18 by HAGER ALICIA J.
  • 4: filed on 2023-01-18 by BRANDENBERGER RALPH
  • 3: filed on 2023-01-10 by SHOOK DAVID
  • 4: filed on 2022-10-07 by BRANDENBERGER RALPH
  • 4: filed on 2022-09-30 by HASTINGS PAUL J
  • 4: filed on 2022-09-22 by HASTINGS PAUL J

    • Events (8k)

  • 8-K: filed on 2023-03-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-05:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-02:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-10:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-28:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HASTINGS PAUL J CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,016,403 2023-01-13 4

    HAGER ALICIA J. CHIEF LEGAL OFFICER

    • Officer
    		 190,497 2023-01-13 2

    TRAGER JAMES CHIEF SCIENTIFIC OFFICER

    • Officer
    		 273,229 2023-01-13 3

    MAHMOOD NADIR SEE REMARKS

    • Officer
    		 244,726 2023-01-13 5

    BRANDENBERGER RALPH CHIEF TECHNICAL OFFICER

    • Officer
    		 99,109 2023-01-13 8

    SHOOK DAVID CHIEF MEDICAL OFFICER

    • Officer
    		 195,779 2023-01-13 2

    PATTERSON LEONE D

    • Director
    		 16,000 2022-06-08 1

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 16,000 2022-06-08 1

    SHAWVER LAURA

    • Director
    		 16,000 2022-06-08 1

    GEORGE SIMEON

    • Director
    		 16,000 2022-06-08 2

    DYBBS MICHAEL

    • Director
    		 16,000 2022-06-08 1

    BEHBAHANI ALI

    • Director
    		 16,000 2022-06-08 1

    AYNECHI TIBA

    • Director
    		 16,000 2022-06-08 1

    THEDINGA ANGELA

    • Director
    		 3,218 2022-06-08 3

    SCHEINER ZACHARY

    • Director
    		 16,000 2022-06-08 1

    AZZAM FOUAD OSCAR

    • Director
    		 16,000 2022-06-08 1

    RAJANGAM KANYA CHIEF MEDICAL OFFICER

    • Officer
    		 89,600 2022-01-14 0

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 5,605,129 2021-04-01 1

    FLYNN JAMES E

    DEERFIELD MGMT IV, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 No longer subject to file 2020-07-14 0

    GLAXOSMITHKLINE PLC

    • Director
    • 10% Owner
    		 3,150,732 2020-07-14 0

    MAKOWER JOSHUA

    • 10% Owner
    		 2,902,115 2020-07-14 0

    SANDELL SCOTT D

    • 10% Owner
    		 2,902,115 2020-07-14 0

    BASKETT FOREST

    • 10% Owner
    		 2,902,115 2020-07-14 0

    RA CAPITAL MANAGEMENT, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    		 5,605,129 2020-07-14 0

    NOVO HOLDINGS A/S

    • 10% Owner
    		 No longer subject to file 2020-07-14 0

    SONSINI PETER W.

    • 10% Owner
    		 2,902,115 2020-07-14 0

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    		 2,902,115 2020-07-14 0

    NEW ENTERPRISE ASSOCIATES 15, L.P.

    NEA PARTNERS 15, L.P.

    NEA 15 GP, LLC

    • 10% Owner
    		 2,902,115 2020-07-14 0

    MAKHZOUMI MOHAMAD

    • 10% Owner
    		 2,902,115 2020-07-14 0

    PLUNKETT MATTHEW CHIEF FINANCIAL OFFICER

    • Officer
    		 37,499 2020-07-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NKARTA INC NKTX 2023-03-20 13:15:04 UTC 4.0853 0.4847 2000000
    NKARTA INC NKTX 2023-03-20 12:45:03 UTC 4.0853 0.4847 2000000
    NKARTA INC NKTX 2023-03-17 22:15:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 21:45:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 21:15:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 20:45:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 20:15:06 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 19:45:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 19:15:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 18:45:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 18:15:03 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 17:45:04 UTC 4.0853 0.4847 2200000
    NKARTA INC NKTX 2023-03-17 17:15:05 UTC 4.0853 0.4847 2100000
    NKARTA INC NKTX 2023-03-17 16:45:03 UTC 4.0863 0.4837 2100000
    NKARTA INC NKTX 2023-03-17 16:15:04 UTC 4.0863 0.4837 2100000
    NKARTA INC NKTX 2023-03-17 15:45:04 UTC 4.0863 0.4837 2100000
    NKARTA INC NKTX 2023-03-17 15:15:03 UTC 4.0863 0.4837 2000000
    NKARTA INC NKTX 2023-03-17 14:45:03 UTC 4.0863 0.4837 2000000
    NKARTA INC NKTX 2023-03-17 14:15:04 UTC 4.0863 0.4837 2000000
    NKARTA INC NKTX 2023-03-17 13:45:03 UTC 4.1107 0.4593 2000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund NKTX -10172.0 shares, $-133863.52 2022-09-30 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund NKTX -3928.0 shares, $-49532.08 2022-10-31 N-PORT
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund NKTX -534.0 shares, $-6733.74 2022-10-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund NKTX -995.0 shares, $-5960.05 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments